Inbal, A <br/><br/>
Assessment of the coagulation profile in hemato-oncological patients receiving ATG-based conditioning treatment for allogeneic stem cell transplantation.  [electronic resource] 

 -  Bone marrow transplantation  Sep 2004 
 - 459-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1704609  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antilymphocyte Serum--administration & dosage<br/>Blood Coagulation<br/>CD40 Ligand--blood<br/>Female<br/>Hematologic Neoplasms--epidemiology<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Incidence<br/>Male<br/>Methylenetetrahydrofolate Reductase (NADPH2)--genetics<br/>Middle Aged<br/>Polymorphism, Genetic<br/>Prevalence<br/>Risk Factors<br/>Thrombosis--blood<br/>Transplantation Conditioning<br/>Transplantation, Homologous